NEWS & EVENTS
NEWS & EVENTS.
IntelliSyn was awarded at the 2018 Alpha Gala of the Chamber of Commerce and Industry of Saint-Laurent – Mount Royal.
IntelliSyn is proud to sponsor the 2017-2018 Prestigious Conference at the University of Montreal. This year’s lecture on May 23rd 2018 features Professor Ilan Marek of Technion – Israel Institute of Technology, Israel.
The organometallic catalyst Pd-PEPPSI was awarded the “2017 EROS Reagent of the Year.” This catalyst was developed by IntelliSyn scientist Dr. Adam M. Sayah during his graduate work under the direction of Prof. Michael. G. Organ at York University. This important catalyst has become widely used for challenging cross-coupling reactions. It has emerged as a leading catalyst for coupling secondary alkyl-Zinc reagents to aryl/heteroaryl halides (Negishi reactions) with excellent regioselectivity. Congratulations to Prof. Organ, Adam, and the Organ research team.
Published review on organometallic catalysis. The second volume in the prestigious “Science of Synthesis” series has just been published on “N-Heterocyclic Carbenes in Catalytic Organic Synthesis.” In their monograph, IntelliSyn Scientist, Dr. Michael Mulholland and his former research advisor, Prof. Shawn Collins review asymmetric reactions catalyzed by chiral N-heterocyclic carbene (NHC) complexes. They summarize the different NHC ligand types that have been developed, including both monodentate/bidentate and C1- and C2-symmetric ligands. In addition, they describe the use of such ligands in a variety of asymmetric transformations and their applications in the construction of complex molecules.
IntelliSyn Pharma is proud to sponsor the Fondation Lucien-Piché that awards scholarships to the best finishing students enrolled in undergraduate chemistry programs within the province of Quebec.
100th Canadian Chemistry Conference and Exhibition, IntelliSyn is sponsoring and will be participating at the CSC meeting in Toronto, Canada on May 28-June 1, 2017. We will be hosting interviews for job seekers at the M.Sc. and Ph.D. levels; please contact us by email for more details.
Gordon Research Conference in Medicinal Chemistry, IntelliSyn will be presenting on the design and analysis of allosteric modulators at the Gordon Research Conference at Colby-Sawyer College in New London, NH on August 6-11, 2017.
254th American Chemical Society, IntelliSyn will be participating at the 254th ACS meeting in Washington, DC on August 20-24, 2017.
19th Royal Society of Chemistry Symposium. IntelliSyn will be participating at the RSC Med Chem Symposium in Cambridge, United Kingdom from September 10-13, 2017
Pharma ChemOutsourcing, IntelliSyn will be participating at the ChemOutsourcing meeting in Long Branch, NJ on September 18-20, 2017 and stop at Booth 117 to visit us.
8th Banff Symposium on Organic Chemistry. IntelliSyn is proud to sponsor and will be participating at the BSOC meeting in Banff, Alberta from October 27-30, 2017. We will be hosting interviews for job seekers at the M.Sc. and Ph.D. levels; please contact us by email for more details.
Proventa Drug Discovery Conference, San Francisco, USA. November 1, 2017; IntelliSyn will be presenting on Challenges and Developments in the Design of Biased-Signalling GPCR Modulators.
28th annual Quebec-Ontario Mini-Symposium for Synthetic and Bioorganic Chemistry. IntelliSyn is sponsoring and will be participating at the QOMSBOC meeting hosted by McGill University in Montreal, Canada from November 17-19, 2017. We will be hosting interviews for job seekers at the M.Sc. and Ph.D. levels; please contact us by email for more details.
Global Medicinal Chemistry & GPCR summit. IntelliSyn is proud to be participating next week to the Global Medicinal Chemistry & GPCR summit in London, United Kingdom from November 27-28, 2017. Jeffrey Albert will be presenting on ”Emerging approaches for effective lead generation”.
Create Continuous Flow Workshop. IntelliSyn will be participating in the Create Continuous Flow Workshop on April 17th, 2018 at the University of Montreal.
256th American Chemical Society, IntelliSyn will be participating at the 256th ACS meeting in Boston, MA on August 19-23, 2018. In particular come see us at the following sessions: (1) “Best Practices in Fragment-Based Design”, Monday Aug 20, 9:00-11:55, (2) “Structure-Based Drug Design for GPCRs & other Difficult Targets”, Tuesday Aug 21, 1:30-5:30, and (3) “First Time Disclosure of Clinical Candidates”, Wednesday Aug 22, (9:00-11:50).
Pharma ChemOutsourcing, IntelliSyn will be participating at the ChemOutsourcing meeting in Long Branch, NJ on September 17-19, 2018 and stop at Booth 109 to visit us.